Upon completion of this session, attendees will have an understanding of
FDA compliance and enforcement as it relates to computer system
validation. They will understand how to develop the most robust
computer system validation compliance program, focusing on the critical
areas of interest to FDA. The attendees will have a good grasp of how
to identify potential weaknesses and findings, as well as how to make
recommendations for addressing and remediating them through risk
In particular, we will focus on best practices for validating computer systems regulated by FDA and meeting compliance with electronic records and electronic signatures (21 CFR Part 11). We will also provide current FDA trends, including a focus on data integrity issues in industry, which will be illustrated through industry examples.
The webinar will cover what you need to do to prepare for an FDA audit, and also the importance and steps required to be certain you have audited all vendors of regulated systems appropriately.
Effective and compliant computer system validation is critical to any
FDA-regulated organization. FDA has set forth very specific
requirements for meeting compliance, and a very prescriptive set of
enforcement actions to protect patient and/or consumer safety. This
course will enable you to best anticipate and prepare for FDA scrutiny,
understand your role during inspections and audits, and gain insight to
the level of enforcement associated with various findings, consent
decrees and warning letters. Examples from industry will be used as
case studies to illustrate these.
It is vital for regulated companies to maintain a pulse on the regulatory environment in order to fortify system validation efforts, as necessary, to meet FDA expectations. It is the best practice to have a robust computer system validation, continue executing against it consistently, and documenting it thoroughly. By maintaining a strong and consistent computer system validation program, companies can further build trust with FDA and the consumers who rely on such oversight for protection.